SE445215B - 4-hydroxi-3-metoxi-n-(2-(2-(1-metyl-2-piperidinyl)etyl)fenyl)bensamid,forfarande for framstellning av denna, samt en farmaceutisk komposition med antiarytmisk aktivitet - Google Patents

4-hydroxi-3-metoxi-n-(2-(2-(1-metyl-2-piperidinyl)etyl)fenyl)bensamid,forfarande for framstellning av denna, samt en farmaceutisk komposition med antiarytmisk aktivitet

Info

Publication number
SE445215B
SE445215B SE8105538A SE8105538A SE445215B SE 445215 B SE445215 B SE 445215B SE 8105538 A SE8105538 A SE 8105538A SE 8105538 A SE8105538 A SE 8105538A SE 445215 B SE445215 B SE 445215B
Authority
SE
Sweden
Prior art keywords
compound
ethyl
benzamide
piperidinyl
hydroxy
Prior art date
Application number
SE8105538A
Other languages
English (en)
Swedish (sv)
Other versions
SE8105538L (sv
Inventor
R F Mayol
R E Gammans
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of SE8105538L publication Critical patent/SE8105538L/xx
Publication of SE445215B publication Critical patent/SE445215B/sv

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
SE8105538A 1980-09-18 1981-09-18 4-hydroxi-3-metoxi-n-(2-(2-(1-metyl-2-piperidinyl)etyl)fenyl)bensamid,forfarande for framstellning av denna, samt en farmaceutisk komposition med antiarytmisk aktivitet SE445215B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/188,184 US4332803A (en) 1980-09-18 1980-09-18 Benzanilide derivative

Publications (2)

Publication Number Publication Date
SE8105538L SE8105538L (sv) 1982-03-19
SE445215B true SE445215B (sv) 1986-06-09

Family

ID=22692080

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8105538A SE445215B (sv) 1980-09-18 1981-09-18 4-hydroxi-3-metoxi-n-(2-(2-(1-metyl-2-piperidinyl)etyl)fenyl)bensamid,forfarande for framstellning av denna, samt en farmaceutisk komposition med antiarytmisk aktivitet

Country Status (25)

Country Link
US (1) US4332803A (fr)
JP (1) JPS5782368A (fr)
AR (1) AR227065A1 (fr)
AT (1) AT378181B (fr)
AU (1) AU526825B2 (fr)
BE (1) BE890418A (fr)
CA (1) CA1183537A (fr)
CH (2) CH650497A5 (fr)
CY (2) CY1370A (fr)
DE (2) DE3153300C2 (fr)
DK (1) DK152121C (fr)
FI (1) FI66597C (fr)
FR (1) FR2494267B1 (fr)
GB (2) GB2084570B (fr)
GR (1) GR75788B (fr)
HK (2) HK5388A (fr)
IE (1) IE51584B1 (fr)
IT (1) IT1209900B (fr)
KE (2) KE3717A (fr)
LU (1) LU83644A1 (fr)
NL (1) NL8104261A (fr)
SE (1) SE445215B (fr)
SG (1) SG30187G (fr)
YU (1) YU42425B (fr)
ZA (1) ZA816348B (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4618680A (en) * 1980-09-18 1986-10-21 Mead Johnson & Company Benzanilide derivative

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3931195A (en) * 1971-03-03 1976-01-06 Mead Johnson & Company Substituted piperidines
CA961038A (en) * 1971-03-03 1975-01-14 Joseph L. Minielli Substituted piperidines

Also Published As

Publication number Publication date
DK412881A (da) 1982-03-19
AT378181B (de) 1985-06-25
BE890418A (fr) 1982-03-18
SE8105538L (sv) 1982-03-19
LU83644A1 (fr) 1982-04-14
YU219281A (en) 1984-02-29
GB2084570B (en) 1984-09-05
ZA816348B (en) 1982-09-29
FI812873L (fi) 1982-03-19
YU42425B (en) 1988-08-31
GR75788B (fr) 1984-08-02
IT8149311A0 (it) 1981-09-17
AU7518181A (en) 1982-03-25
CY1370A (en) 1987-08-07
GB2144050B (en) 1985-09-11
CH650497A5 (de) 1985-07-31
CA1183537A (fr) 1985-03-05
FI66597B (fi) 1984-07-31
DK152121B (da) 1988-02-01
JPS5782368A (en) 1982-05-22
CY1377A (en) 1987-08-07
AU526825B2 (en) 1983-02-03
DK152121C (da) 1988-06-20
AR227065A1 (es) 1982-09-15
GB8402839D0 (en) 1984-03-07
US4332803A (en) 1982-06-01
FI66597C (fi) 1984-11-12
KE3716A (en) 1987-04-16
FR2494267B1 (fr) 1986-06-27
KE3717A (en) 1987-04-16
HK5388A (en) 1988-01-29
DE3153300C2 (de) 1987-03-19
HK4488A (en) 1988-01-29
ATA403781A (de) 1984-11-15
IT1209900B (it) 1989-08-30
DE3137084C2 (de) 1986-04-10
GB2144050A (en) 1985-02-27
FR2494267A1 (fr) 1982-05-21
NL8104261A (nl) 1982-04-16
GB2084570A (en) 1982-04-15
IE51584B1 (en) 1987-01-21
DE3137084A1 (de) 1982-05-13
CH651932A5 (de) 1985-10-15
SG30187G (en) 1987-07-17
IE812160L (en) 1982-03-18
JPH0256351B2 (fr) 1990-11-29

Similar Documents

Publication Publication Date Title
EP0244080A2 (fr) Médicament pour le traitement de l'obésité
US20040043083A1 (en) Anticancer composition comprising sesquiterpenes isolated from resina ferulae
JPS6322082A (ja) １―（ヒドロキシスチリル）―５ｈ―２，３―ベンゾジアゼピン誘導体およびその製造方法、並びに前記誘導体を含む薬剤
EP0085870B1 (fr) Dérivés de dibenz(b,d)oxépine et compositions pharmaceutiques les contenant
SE445215B (sv) 4-hydroxi-3-metoxi-n-(2-(2-(1-metyl-2-piperidinyl)etyl)fenyl)bensamid,forfarande for framstellning av denna, samt en farmaceutisk komposition med antiarytmisk aktivitet
EP0448029B1 (fr) Nouvelles utilisations pharmaceutiques des dérivés de la forskoline
EP0074411B1 (fr) Derives de l'acide ascorbique
KR100407849B1 (ko) 헬리코박터의감염에기인하는질환의치료제
US5362726A (en) Compound and method of treatment for falciparum malaria
US4618680A (en) Benzanilide derivative
US20050014751A1 (en) Use of n-acyl homoserine lactones for the treatment of insulitis
JPS63135378A (ja) ブチロラクトン誘導体、その製造方法およびその用途
JPH032183A (ja) ビスベンジルイソキノリン誘導体
EP1621196A1 (fr) Agent therapeutique et/ou preventif pour une maladie de peau chronique
JP2860385B2 (ja) ビスべンジルイソキノリン誘導体
JPH0723358B2 (ja) ピロールの新規アロイル誘導体
JPS6112624A (ja) 抗高血圧剤
JP2694321B2 (ja) インターロイキン−１阻害剤
RU2228753C2 (ru) Изоникотиноилгидразид фталевой кислоты, проявляющий гипогликемическую активность
JPH0368578A (ja) ビスベンジルイソキノリン誘導体
JP3949197B2 (ja) Ｍｒｓａ感染防御剤
NO152750B (no) Fremgangsmaate for fremstilling av nitrogen brohode-kondenserte pyrimidinforbindelser
EP0343832A2 (fr) Composés de 5H-pyrazolo(4,3-a)quinolizin-5-one aux activités thérapeutiques
GB2106910A (en) 2,5-anhydro-d-mannitol and esters thereof
JPH11193264A (ja) 新規アミノ酸誘導体

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8105538-6

Effective date: 19940410

Format of ref document f/p: F